Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plocabulin in advanced colorectal cancer
NCT03427268Phase 2Completed
- Sponsor
- PharmaMar
- Start
- Jan 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of plocabulin in colorectal cancer (CRC), sponsored by PharmaMar. Started Jan 2018; status: completed.
02
Drugs
plocabulin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03427268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03427268.